Victory Capital Management
LXRX icon

Victory Capital Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$20K Sell
21,115
-518
-2% -$490 ﹤0.01% 2443
2025
Q1
$9.97K Buy
21,633
+774
+4% +$357 ﹤0.01% 2454
2024
Q4
$15.4K Sell
20,859
-23,448
-53% -$17.3K ﹤0.01% 2456
2024
Q3
$69.6K Sell
44,307
-1,034
-2% -$1.62K ﹤0.01% 2359
2024
Q2
$76.2K Buy
45,341
+13,972
+45% +$23.5K ﹤0.01% 2329
2024
Q1
$75.3K Sell
31,369
-818
-3% -$1.96K ﹤0.01% 2332
2023
Q4
$49.2K Buy
32,187
+5,813
+22% +$8.89K ﹤0.01% 2437
2023
Q3
$28.7K Buy
26,374
+6,123
+30% +$6.67K ﹤0.01% 2425
2023
Q2
$46.4K Sell
20,251
-472
-2% -$1.08K ﹤0.01% 2395
2023
Q1
$50.4K Buy
20,723
+300
+1% +$729 ﹤0.01% 2444
2022
Q4
$39K Sell
20,423
-10
-0% -$19 ﹤0.01% 2472
2022
Q3
$49K Buy
20,433
+8,873
+77% +$21.3K ﹤0.01% 2569
2022
Q2
$22K Sell
11,560
-23
-0.2% -$44 ﹤0.01% 2607
2022
Q1
$21K Sell
11,583
-16,368
-59% -$29.7K ﹤0.01% 2638
2021
Q4
$110K Buy
27,951
+6,986
+33% +$27.5K ﹤0.01% 2560
2021
Q3
$101K Buy
20,965
+10,272
+96% +$49.5K ﹤0.01% 2616
2021
Q2
$49K Buy
10,693
+578
+6% +$2.65K ﹤0.01% 2664
2021
Q1
$59K Sell
10,115
-2,211
-18% -$12.9K ﹤0.01% 2656
2020
Q4
$42K Buy
+12,326
New +$42K ﹤0.01% 2469
2020
Q2
Sell
-107,936
Closed -$210K 2936
2020
Q1
$210K Buy
107,936
+57,731
+115% +$112K ﹤0.01% 2318
2019
Q4
$208K Sell
50,205
-6,314
-11% -$26.2K ﹤0.01% 2302
2019
Q3
$170K Buy
56,519
+55,014
+3,655% +$165K ﹤0.01% 2269
2019
Q2
$9K Hold
1,505
﹤0.01% 1812
2019
Q1
$8K Hold
1,505
﹤0.01% 1767
2018
Q4
$10K Sell
1,505
-287
-16% -$1.91K ﹤0.01% 1765
2018
Q3
$19K Sell
1,792
-80,015
-98% -$848K ﹤0.01% 1759
2018
Q2
$982K Sell
81,807
-4,520
-5% -$54.3K ﹤0.01% 1262
2018
Q1
$739K Buy
86,327
+84,770
+5,444% +$726K ﹤0.01% 1295
2017
Q4
$15K Hold
1,557
﹤0.01% 1797
2017
Q3
$19K Hold
1,557
﹤0.01% 1778
2017
Q2
$26K Buy
1,557
+27
+2% +$451 ﹤0.01% 1762
2017
Q1
$22K Hold
1,530
﹤0.01% 1771
2016
Q4
$21K Buy
1,530
+86
+6% +$1.18K ﹤0.01% 1757
2016
Q3
$26K Buy
+1,444
New +$26K ﹤0.01% 1738